Cargando…
Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer
Heparanase, the sole heparan sulfate (HS) degrading endoglycosidase, regulates multiple biological activities that enhance tumor growth, metastasis, angiogenesis, and inflammation. Heparanase accomplishes this by degrading HS and thereby facilitating cell invasion and regulating the bioavailability...
Autores principales: | Katz, Amit, Barash, Uri, Boyango, Ilanit, Feld, Sari, Zohar, Yaniv, Hammond, Edward, Ilan, Neta, Kremer, Ran, Vlodavsky, Israel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922397/ https://www.ncbi.nlm.nih.gov/pubmed/29721203 http://dx.doi.org/10.18632/oncotarget.25022 |
Ejemplares similares
-
The prognostic significance of heparanase expression in metastatic melanoma
por: Vornicova, Olga, et al.
Publicado: (2016) -
Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
por: Vornicova, Olga, et al.
Publicado: (2017) -
New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021) -
The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression()
por: Singh, Preeti, et al.
Publicado: (2017) -
Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation
por: Kayal, Yasmin, et al.
Publicado: (2023)